HSCSW (HeartSciences) Short-Term Debt: $3.62 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSCSW HeartSciences Inc HSCSW
18 GF Score
Price $0.07
! 10 Warning Signs
View Full Analysis

What is HeartSciences Short-Term Debt?

HeartSciences HSCSW 18 Short-Term Debt is $3.62 Mil as of Apr. 2026. GuruFocus rates HSCSW with a GF Score™ of 18/100. The stock has 10 warning signs investors should review.

HeartSciences's Short-Term Debt for the quarter that ended in Apr. 2026 was $3.62 Mil.

HeartSciences's quarterly Short-Term Debt increased from Oct. 2025 ($0.50 Mil) to Jan. 2026 ($3.10 Mil) and increased from Jan. 2026 ($3.10 Mil) to Apr. 2026 ($3.62 Mil).

HeartSciences's annual Short-Term Debt increased from Apr. 2024 ($0.50 Mil) to Apr. 2025 ($2.55 Mil) and increased from Apr. 2025 ($2.55 Mil) to Apr. 2026 ($3.62 Mil).

HeartSciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

HeartSciences Short-Term Debt Related Terms

HeartSciences Short-Term Debt Historical Data

* Premium members only.

The historical data trend for HeartSciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Short-Term Debt Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Short-Term Debt
Get a 7-Day Free Trial 1.63 0.50 0.50 2.55 3.62

HeartSciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.55 1.54 0.50 3.10 3.62
HSCSW
18GF Score
HeartSciences Inc HSCSW
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $3.62 Mil mean?
HeartSciences (HSCSW) has a Short-Term Debt of $3.62 Mil as of Apr. 2026.
Is HeartSciences' Short-Term Debt too high?
HeartSciences' current Short-Term Debt is $3.62 Mil. Overall, HeartSciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Short-Term Debt compare to IRIX and ALRTF?
HeartSciences' Short-Term Debt of $3.62 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. HeartSciences's current Short-Term Debt is $3.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
HeartSciences (HSCSW) has a current Short-Term Debt of $3.62 Mil. The current Short-Term Debt is $3.62 Mil. HeartSciences' overall GF Score™ is 18/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For HeartSciences (HSCSW), the current Short-Term Debt is $3.62 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartSciences Business Description

Other Exchanges HSCS:USA
Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
18GF Score

Get the complete analysis for HSCSW

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price